Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer

被引:26
|
作者
Haroun, Iman
Graham, Tracy
Poll, Aletta
Sun, Ping
Hill, Kimberley [1 ]
Weitzner, Eleanor [2 ]
Narod, Steven [3 ]
Warner, Ellen [3 ]
机构
[1] Sunnybrook Odette Canc Ctr, Dept Med, Div Med Oncol, Toronto, ON, Canada
[2] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON M5S 1A1, Canada
来源
BREAST | 2011年 / 20卷 / 03期
关键词
BRCA1; MRI; Mastectomy; BRCA2; Surveillance; BILATERAL PROPHYLACTIC MASTECTOMY; BRCA2 MUTATION CARRIERS; TAMOXIFEN; IMPACT;
D O I
10.1016/j.breast.2011.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To determine the reasons that motivate women in a cohort of women under intensive surveillance for breast cancer to undergo risk-reducing mastectomy (RRM). Patients and methods: Women with a BRCA1 or BRCA2 mutation who were enrolled in an MRI-based breast screening study were eligible to participate in this survey. A self-administered questionnaire was given to women who did, and who did not terminate annual MRI-based surveillance in order to undergo RRM. The questionnaire included information on family history, risk perception and satisfaction with screening. In addition, women were asked to provide the principal reason for their choice of having preventive surgery or not, and were asked about their satisfaction with this choice. Results: 246 women without breast cancer participated in the study. Of these, 39 women (16%) elected to have RRM at some point after initiating screening. Although women who had a mother or sister with breast cancer were more likely to opt for RRM than were women with no affected first-degree relative (21% versus 10%) this did not reach statistical significance. Women who perceived their breast cancer risk to be greater than 50% were more likely to opt for RRM than were women who estimated their risk to be less than 50% (19% versus 6%). Fear of cancer was the most common reason cited for choosing to have RRM (38% of respondents) followed by having had a previous cancer, (25%), then concern over their children (16%). Conclusion: Among women with a BRCA mutation who are enrolled in an MRI-based screening program, a high perception of personal breast cancer risk and a history of breast cancer in a first-degree relative are predictors of the decision to have RRM. (C) 2011 Published by Elsevier Ltd.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 50 条
  • [41] Screening Breast MRI, Chemoprevention, and Risk-Reducing Surgeries in Unaffected BRCA Carriers
    Beattie, M. S.
    Yu, T.
    Sullivan, H.
    Metrikin, M.
    Crawford, B.
    CANCER RESEARCH, 2009, 69 (24) : 730S - 730S
  • [42] Impact of genetic testing on risk-reducing behavior in women at risk for hereditary gynecologic cancer syndromes
    Matthew B Yurgelun
    Rowena Mercado
    Margery Rosenblatt
    Judy E Garber
    Sapna Syngal
    Elena M Stoffel
    Hereditary Cancer in Clinical Practice, 8 (Suppl 1)
  • [43] Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: A controlled observational study
    Michelsen, Trond M.
    Pripp, Are H.
    Tonstad, Serena
    Trope, Claes G.
    Dorum, Anne
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 82 - 89
  • [44] The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer
    Basu, Narendra Nath
    Hodson, James
    Chatterjee, Shaunak
    Gandhi, Ashu
    Wisely, Julie
    Harvey, James
    Highton, Lyndsey
    Murphy, John
    Barnes, Nicola
    Johnson, Richard
    Barr, Lester
    Kirwan, Cliona C.
    Howell, Sacha
    Baildam, Andrew D.
    Howell, Anthony
    Evans, D. Gareth
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer
    Narendra Nath Basu
    James Hodson
    Shaunak Chatterjee
    Ashu Gandhi
    Julie Wisely
    James Harvey
    Lyndsey Highton
    John Murphy
    Nicola Barnes
    Richard Johnson
    Lester Barr
    Cliona C. Kirwan
    Sacha Howell
    Andrew D. Baildam
    Anthony Howell
    D. Gareth Evans
    Scientific Reports, 11
  • [46] Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania
    Filip, Claudiu Ioan
    Catana, Andreea
    Kutasi, Eniko
    Roman, Sara Alexia
    Militaru, Mariela Sanda
    Risteiu, Giulia Andreea
    Dindelengan, George Calin
    MEDICINA-LITHUANIA, 2024, 60 (04):
  • [47] Uptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent
    Evans, D. Gareth R.
    Lalloo, Fiona
    Ashcroft, Linda
    Shenton, Andrew
    Clancy, Tara
    Baildam, Andrew D.
    Brain, Anne
    Hopwood, Penelope
    Howell, Anthony
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (08) : 2318 - 2324
  • [48] The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer EDITORIAL COMMENT
    Hartmann, Lynn C.
    Lindor, Noralane M.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2016, 71 (10) : 598 - 599
  • [49] The Importance of Risk-Reducing Prophylactic Mastectomy in Breast Cancer (BRCA) Carriers: A Case Report
    Ochaney, Priyanka
    Patel, Kornai
    Haq, Furcian
    Reese, Robyn
    Igel, Stephen
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (08)
  • [50] Breast MRI screening in Asian women with high familial risk of breast cancer
    Sim, L.
    Ang, P.
    Ho, G. H.
    Tan, P. H.
    EJC SUPPLEMENTS, 2008, 6 (07): : 95 - 95